Amgen Inc (AMGN) - Comprehensive Stock Analysis & Investment Research
Deep dive into Amgen Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Amgen Inc Investment Summary
When evaluating whether Amgen Inc (AMGN) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Amgen Inc (AMGN) operates within the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. The company employs approximately 22,000 people. With a market capitalization of $203 billion, the company is classified as a mega-cap stock, typically characterized by high stability and strong institutional backing.
Financial Performance Analysis
Our comprehensive financial analysis covers Amgen Inc's revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Amgen Inc along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Amgen Inc is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Amgen Inc (Stock Symbol: AMGN) is a prominent company operating within the Life Sciences sector, with a specific focus on the Biological Products, (No Diagnostic Substances) industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Amgen Inc's leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Amgen Inc...
Sector & Industry Analysis
In-depth sector dynamics and industry context for Amgen Inc...
Revenue & Growth Analysis
Amgen Inc generates annual revenues of $37 billion , demonstrating substantial market presence and operational scale.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Amgen Inc...
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Amgen Inc...
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Amgen Inc...
Strategic Market Position
Amgen Inc strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace. As a mega-cap market leader, the company commands significant market influence, enjoying substantial competitive moats including brand recognition, scale economies, and extensive distribution networks. Mega-cap status typically brings advantages in capital access, talent acquisition, and partnership opportunities, while also attracting the highest levels of institutional investor and analyst coverage.
Industry Competitive Landscape
Amgen Inc competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company demonstrates exceptional operational efficiency through free cash flow generation of $8 billion annually , with year-over-year cash flow growth of 14.7%. This substantial cash generation capability provides significant strategic flexibility for acquisitions, share repurchases, dividend growth, or debt reduction—all while maintaining operational investments necessary to defend market position.
Margin & Pricing Power Analysis
The company maintains a 315.5% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.
Operating margin of 100.2% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This strong operating margin indicates excellent cost control and efficient organizational structure relative to the revenue base.
Asset Utilization Efficiency
Asset turnover ratio of 0.43x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.
Financial Strength & Leverage
Current ratio of 1.44 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.